Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

06 Mar 2026 Evaluate

Alembic Pharmaceuticals has informed that Alembic Therapeutics LLC, a step-down wholly owned subsidiary of the company, has reported its first prescription-based sale in the United States of America (US) following the commercial launch of Pivya® (pivmecillinam) tablets, an oral prescription antibiotic. The company has enclosed its press release in this regard.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..